The first ENS@T-HT consortium meeting will take place on the 15th of April 2016 in an ideal remote setting with a beautiful view on the of Lake Garda in Italy.
All partners will be present, the agenda will include updates on the current status of the different WPs but will also give time for scientific discussion and exchange between the partners on the topics of the project.
Paris, 24th September 2015: An international group of scientists from 6 countries bring together their expertise to improve diagnosis and therapeutic care for primary and secondary forms of arterial hypertension. ENS@T-HT, which is coordinated by Maria-Christina Zennaro, Research Director at Inserm (Paris Cardiovascular Research Center), was officially launched this month in Paris and will last 5 years.
Hypertension affects up to 45% of the general population and is responsible for 9.4 million deaths per year worldwide. Even small rises in blood pressure are associated with increased risk of stroke and heart disease. However, despite a large array of available treatments, blood pressure is still not properly controlled in many patients.
Approximately 10% of current hypertension cases could be treated and cured if properly diagnosed. These include disorders of the adrenal gland that increase the production of hormones affecting blood pressure. Correct identification of these disorders is crucial to proper management of the underlying disease and prevention of cardiovascular complications. However, due to the complexity of diagnosis, proper treatment of these conditions can be delayed by several years, exposing patients to increased cardiovascular and metabolic risk and diminished quality of life.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 633983